Scarica l'app Stockscreener
65.73
0.45%
-0.5397
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GEHC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$66.27
Aprire:
$66.16
Volume 24 ore:
424.95K
Relative Volume:
0.10
Capitalizzazione di mercato:
$29.68B
Reddito:
$20.98B
Utile/perdita netta:
$1.98B
Rapporto P/E:
15.74
EPS:
4.177
Flusso di cassa netto:
$1.52B
1 W Prestazione:
+3.91%
1M Prestazione:
-11.83%
6M Prestazione:
-7.93%
1 anno Prestazione:
-11.57%
Intervallo 1D:
$65.62
$66.46
Intervallo di 1 settimana:
$62.99
$67.09
Portata 52W:
$58.75
$89.77
Ge Healthcare Technologies Inc Stock (GEHC) Company Profile
Nome
Ge Healthcare Technologies Inc
Settore
Industria
Telefono
833-735-1139
Indirizzo
500 WEST MONROE STREET, CHICAGO
Compare GEHC vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GEHC
Ge Healthcare Technologies Inc
|
65.72 | 29.93B | 20.98B | 1.98B | 1.52B | 4.177 |
ABT
Abbott Laboratories
|
103.80 | 179.42B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
90.61 | 116.11B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
273.44 | 105.52B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.96 | 65.10B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.33 | 51.17B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ge Healthcare Technologies Inc Stock (GEHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-15 | Downgrade | UBS | Neutral → Sell |
| 2025-10-13 | Iniziato | Barclays | Equal Weight |
| 2025-10-07 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-05 | Aggiornamento | UBS | Sell → Neutral |
| 2025-03-11 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-09-26 | Downgrade | UBS | Neutral → Sell |
| 2024-09-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-09-09 | Iniziato | JP Morgan | Neutral |
| 2024-08-06 | Iniziato | Stifel | Buy |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-02-15 | Iniziato | HSBC Securities | Buy |
| 2024-02-12 | Aggiornamento | UBS | Sell → Neutral |
| 2023-11-30 | Iniziato | Jefferies | Hold |
| 2023-11-27 | Downgrade | UBS | Neutral → Sell |
| 2023-09-19 | Iniziato | Citigroup | Buy |
| 2023-08-25 | Iniziato | Argus | Buy |
| 2023-08-16 | Iniziato | Wells Fargo | Overweight |
| 2023-07-31 | Iniziato | BofA Securities | Neutral |
| 2023-06-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-05-16 | Iniziato | Oppenheimer | Outperform |
| 2023-04-26 | Iniziato | UBS | Neutral |
| 2023-04-19 | Iniziato | Piper Sandler | Overweight |
| 2023-04-10 | Iniziato | BTIG Research | Neutral |
| 2023-03-13 | Iniziato | Evercore ISI | Outperform |
| 2023-02-17 | Iniziato | Mizuho | Buy |
| 2023-01-19 | Iniziato | Redburn | Buy |
Mostra tutto
Ge Healthcare Technologies Inc Borsa (GEHC) Ultime notizie
GE Healthcare Announces Cash Dividend Increas - Moomoo
GE HealthCare names AT&T CFO Pascal Desroches to board effective Jan. 4, 2027 - Bitget
GE Healthcare Technologies Increases Quarterly Dividend to $0.04 a Share, Payable Nov. 13 to Holders of Record Oct. 23 - marketscreener.com
GE HealthCare announces cash dividend increase for third quarter of 2026 - Voice of Alexandria
Press Release: GE HealthCare Announces Cash Dividend Increase for Third Quarter of 2026 - Moomoo
GE HealthCare Technologies Inc. stock rises Tuesday, outperforms market - MarketWatch
GE HealthCare appoints AT&T CFO to board of directors By Investing.com - Investing.com Canada
GE HealthCare Appoints Pascal Desroches to Board Committees - TipRanks
GE appoints Pascal Desroches to its Board and Audit & Talent Committees - TradingView
AT&T CFO to join GE HealthCare (Nasdaq: GEHC) board in 2027 - Stock Titan
GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors - marketscreener.com
GE Healthcare Technologies Inc. Announces Appointment of Pascal Desroches to Board of Directors, Effective January 4, 2027 - marketscreener.com
GE HealthCare stock gains as Needham sets a USD 93 target - AD HOC NEWS
GEHC Could Be Set For A Turnaround — Needham Sees 44% Upside For GE Healthcare After Nearly 21% YTD Slide - Stocktwits
Needham initiates GE HealthCare stock coverage with buy rating - Investing.com
Needham Initiates GE Healthcare Technologies at Buy With $93 Price Target - marketscreener.com
GE HealthCare stock heads into the open after a flat September 21, 2026 close - AD HOC NEWS
Is GE HealthCare Technologies (GEHC) Undervalued On Its CareIntellect AI Launch? - Yahoo Finance
GE HealthCare Technologies Inc. stock rises Monday, still underperforms market - MarketWatch
GE HealthCare stock steadies as Sofie Biosciences deal talks and analyst targets frame valuation - AD HOC NEWS
At US$64.13, Is GE HealthCare Technologies Inc. (NASDAQ:GEHC) Worth Looking At Closely? - Moomoo
GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Navigating a 28.64% Potential Upside - DirectorsTalk Interviews
GE HealthCare Technologies Inc.Common Stock (NQ: GEHC - The Chronicle-Journal
GE HealthCare Technologies Inc. stock rises Thursday, outperforms market - MarketWatch
Securities Fraud Investigation Into GE HealthCare - GlobeNewswire
BTIG reiterates Buy rating on GE HealthCare Techs, $79 price target - TradingView
GE HealthCare (GEHC) Reportedly Eyes $1B Sofie Deal. What Would Ownership Add? - Yahoo Finance
GE HealthCare (GEHC) grants CFO options and 75K RSUs - Stock Titan
GE HealthCare (GEHC) CFO files ownership form with zero reported shares - Stock Titan
GE HealthCare Announces CareIntellect for Operations, Helping Health Systems Optimize Resources and Expand Access to Care - Yahoo Finance
Update: Market Chatter: GE HealthCare in Discussions on $1 Billion Deal to Buy Sofie Biosciences - Yahoo Finance
GE HealthCare Technologies Inc. (GEHC) Stock Analysis: 29% Potential Upside Beckons Investors - DirectorsTalk Interviews
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports - Reuters
GE HealthCare is said to near $1B Sofie Biosciences deal (GEHC:NASDAQ) - Seeking Alpha
GE Healthcare in Talks To Acquire Sofie Biosciences, Maker of Cancer Scan Chemicals - Benzinga
GE HealthCare stock holds near $64 after upbeat July results - ad-hoc-news.de
GE HealthCare, Leo Cancer Care to Collaborate on Imaging, Radiation Therapy Workflows - Imaging Technology News
Is GE HealthCare Stock Underperforming the Nasdaq? - inkl
GE HealthCare and RSNA bring leading cancer imaging expertise to Africa to improve access to cancer care - Zawya
Image Guided Therapy Becomes First Office-Based Lab to Install GE HealthCare's Allia(TM) Moveo - Yahoo Finance
Enterprise Imaging Solutions Market Set to Hit USD 6.69 Billion by 2035, Growing at a CAGR of 11.18% - GlobeNewswire Inc.
GE HealthCare Technologies Inc. stock falls Thursday, underperforms market - MarketWatch
GE HealthCare stock slips as StarGuide GX clearance and Wells Fargo outlook shape sentiment - ad-hoc-news.de
GE HealthCare stock heads into the open after a September 9 slide - ad-hoc-news.de
GE HealthCare Technologies Inc. stock falls Wednesday, underperforms market - MarketWatch
GE HealthCare at Wells Fargo conference: backlog and margins build By Investing.com - Investing.com Nigeria
GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance - Yahoo Finance
Transcript : GE HealthCare Technologies Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 10 - marketscreener.com
Medtronic Is on the Cusp of Becoming a Dividend King. Is the Stock a Buy for Income Investors? - The Motley Fool
GE HealthCare's StarGuide GX 4D SPECT/CT Now FDA 510(k) Pending - Imaging Technology News
GE HealthCare aims to advance a new era in theranostics with Sta - GuruFocus
Ge Healthcare Technologies Inc Azioni (GEHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ge Healthcare Technologies Inc Azioni (GEHC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hochman Rodney F | Director |
May 12 '26 |
Buy |
62.03 |
1,618 |
100,365 |
1,618 |
| Yang Watkin Phoebe L. | Director |
May 08 '26 |
Buy |
63.01 |
1,000 |
63,006 |
13,702 |
| CULP H LAWRENCE JR | Director |
May 06 '26 |
Buy |
61.88 |
80,805 |
5,000,076 |
151,207 |
| Stromberg William J | Director |
May 06 '26 |
Buy |
61.69 |
1,000 |
61,689 |
15,330 |
| SACCARO JAMES | Chief Financial Officer |
May 01 '26 |
Buy |
60.60 |
3,310 |
200,585 |
87,471 |
| Jimenez Frank R | GC & Corporate Secretary |
Apr 30 '26 |
Buy |
60.45 |
1,750 |
105,788 |
93,932 |
| Arduini Peter J | President and CEO |
Apr 30 '26 |
Buy |
59.92 |
4,169 |
249,827 |
259,424 |
0.01%
0.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):